| INTRODUC TI ON
Obesity is a chronic health problem and has reached worldwide epidemic proportions.
1 Obesity is associated with an increased risk of obesity-related comorbidities such as type 2 diabetes (T2DM), dyslipidemia, hypertension and sleep apnea syndrome (SAS). In Japanese patients, T2DM tends to become severe at a relatively lower BMI. [2] [3] [4] [5] Hence, obesity is also a critical health problem in Japan. Treatment of obesity aims to restore the imbalance between energy intake and energy expenditure. However, conventional approaches such as lifestyle modification, dietary control, increasing physical activity and pharmacotherapy are usually insufficient to achieve satisfactory weight loss.
Bariatric surgery has become a popular treatment option for obesity. Laparoscopic Roux-en-Y gastric bypass was the most widely used bariatric procedure and, recently, laparoscopic sleeve gastrectomy (LSG) as a single-stage procedure is becoming more popular worldwide. 6 In Japan, LSG is the only bariatric procedure which is covered by the national health insurance and is therefore the main procedure used. A Japanese multi-institutional survey reported that % total weight loss (%TWL) was 29% at 1 year and complete or partial diabetes remission rate was 85% after LSG. 7 The results are comparable to similar surveys in American and European countries. In contrast, insufficient weight loss is often observed in patients after undergoing LSG, but background characteristics of these patients and the effect of LSG on obesity-related comorbidities have not been fully investigated in Japan. The cause of obesity is multifactorial, including genetic, social, economic, educational, environmental and psychological factors.
Therefore, there is a possibility that these preoperative factors predict success or failure of postoperative weight loss. The number of patients who undergo bariatric surgery in Japan is still quite low compared with American, European and other Asian countries. We established a retrospective study group "Japanese Survey of Morbid and TreatmentResistant Obesity" (J-SMART). The aim of the present study was to investigate the effects of LSG on obesity-related comorbidities and to identify the background characteristics of Japanese obese patients with insufficient weight loss after LSG. 
| SUBJEC TS AND ME THODS

| RE SULTS
| Weight loss
Changes in body weight and BMI at various time points are shown in Table 1 . After LSG, rapid weight loss was observed during the ini- 1 year and 29.9% at 2 years. Figure 1 shows a histogram of %TWL at 2 years after LSG. Frequencies of %TWL <15% and <20% at 2 years, which were indicators of insufficient weight loss, were 6.5% and 18.5%, respectively (data not shown). Changes in VFA and SFA are shown in Table 1 , and both decreased significantly in all postoperative periods compared to the first visit.
| Changes in metabolic parameters and relationship with %TWL
After LSG, mean HbA1c and FBG decreased rapidly to 5.9% and 96.5 mg/ dL, respectively, at 1 year, and to 5.7% and 97.8 mg/dL at 2 years ( Metabolic parameters at the first visit in patients stratified by %TWL are shown in Table 2 . One-way ANOVA detected no statistically significant differences in all of the metabolic parameters studied among the %TWL groups. Simple linear regression analysis showed that %TWL correlated positively with preoperative body weight (r = .281, P < .0001), BMI (r = .313, P < .0001) and VFA (r = .281, P < .0001) (data not shown). Figure 2A compares the 2-year metabolic remission rates among %TWL groups. Diabetes CR rate was above 80% when %TWL was ≥20%, but decreased to below 60% when %TWL was <20%. Diabetes CR rates in %TWL ≤14.9% and 15.0%-19.9% groups were significantly lower compared to other groups. ROC curve of %TWL at the optimal cut-off level of diabetes CR is shown in Figure 2B . At the cut-off level (20.8%), sensitivity was 86.2% and specificity was 52.7%. Remission rate of dyslipidemia also decreased in low %TWL groups. Remission rate in %TWL ≤14.9% group was 17.7% and was significantly lower than that in %TWL ≥30.0% group (77.3%). The remission rate of hypertension was lower than the other metabolic remissions and did not differ significantly among %TWL groups.
| Other obesity-related comorbidities
Changes in markers of liver and renal functions, and uric acid from the first visit to various postoperative periods are shown in Table 1 .
Liver function markers and serum uric acid decreased significantly in all postoperative periods, and renal markers decreased significantly at 1 year after LSG. Prevalence of heart failure, menstrual disorder in females, joint disorders and SAS at first visit was 1.3%, 21.3%, 45.4% and 62.8%, respectively (Table 1) . After LSG, the prevalence of menstrual disorder, joint disorders and SAS decreased significantly. The prevalence of other obesity-related comorbidities at first visit in patients stratified by %TWL is shown in Table 3 . There were no significant differences among the %TWL groups. Simple linear regression analysis showed that %TWL correlated positively with AHI in patients with SAS (r = .228 and P = .0016, data not shown), but did not correlate with other obesity-related comorbidities (data not shown).
| Psychosocial background, eating behavior and physical activity
Parameters for psychosocial background, eating behavior and physical activity at first visit in patients stratified by %TWL are shown in Table 3 . Mean prevalence of mental disorders was 26.3%, of which mental retardation/developmental disorders and binge eating were 4.5% and 20.8%, respectively. Frequency of childhood-onset obesity was 38.5%. Mean daily calorie intake was 2997.5 kcal/d at first visit, and decreased significantly in all postoperative periods (Table 1 ). There were no significant differences among the %TWL groups for all of the parameters of psychosocial background, smoking, alcohol, daily calorie intake and ratio of protein, fat and carbohydrate intake (Table 3 ). Figure 3A shows the prevalence of mental disorders stratified by %TWL. To investigate the characteristics of patients not only with insufficient weight loss, but also those with excessive weight loss after LSG, the patients were divided into eight groups according to %TWL (≤14.9%, Figure 3A ). In patients with %TWL <15%, the frequency was 46.9% and significantly higher than in those with %TWL ≥15% ( Figure 3B ).
Similarly, the prevalence of mental retardation and developmental disorders in patients with %TWL <15% tended to be higher than in those with %TWL ≥15% (P = .0817) (data not shown). Furthermore, the prevalence of mental disorders in patients with %TWL ≥45% was also significantly higher than in those with %TWL <45% (Figure 3C ).
| Characteristics of patients with %TWL <15%
As mentioned above, patients with %TWL <15% had a high prevalence of mental disorders. Therefore, to clarify the characteristics F I G U R E 1 Histogram of percent total weight loss (%TWL) at 2 y after laparoscopic sleeve gastrectomy. Patients were divided into eight groups according to %TWL (every 5% of TWL). Black dotted line indicates mean %TWL (29.9 ± 11.0%) of patients with %TWL <15%, further investigation was carried out (Figure 4 ). Patients with %TWL <15% not only had a smaller decrease in body weight compared to patients with %TWL ≥15%, they also showed significant weight regain from 1 year to 2 years after LSG (P = .0002). Patients with %TWL <15% had significantly higher daily calorie intake at 2 years after LSG than those with %TWL ≥15% (P < .0001) and showed a significant increase in calorie intake from 1 year to 2 years after surgery (P = .0486).
| D ISCUSS I ON
This is the first nationwide survey at 10 certified bariatric institutions to clarify the relationship between insufficient weight loss after LSG, metabolic remission and psychosocial background in Japanese patients. In a Japanese survey (published in Japanese), 100-200 patients per year underwent LSG between 2011 and 2014, and there were 10 institutions that carried out more than 10 bariatric/metabolic surgery cases in 2015. Therefore, the sample size in the present study could correspond to that nationwide. LSG has been established as a safe and effective procedure worldwide.
13-15
Seki et al 16 reported that LSG is safe, effective, and acceptably durable for up to 5 years in morbidly obese Japanese patients. Our study found mean %TWL of 29.9% and diabetes CR of 75.6% at 2 years after surgery, together with high remission rates of other metabolic diseases. These findings are consistent with the results of a previous Japanese multi-institutional survey. Cr (mg/dL) 0.8 ± 0.7 0.7 ± 0.2 0.8 ± 0.4 1.1 ± 1.9 0.7 ± 0.2 0.7 ± 0.2 Uric acid (mg/dL) 6.3 ± 1.6 5.7 ± 1.5 6.8 ± 1.7 6.5 ± 1.6 6.2 ± 1.6 6.2 ± 1.6
Note: One-way ANOVA detected no statistically significant differences in all metabolic parameters studied among the %TWL groups. Abbreviations: ALT, alanine transaminase; AST, aspartate aminotransferase; BMI, body mass index; CPR, C-peptide response; Cr, creatinine; FBG, fasting blood glucose; HbA1c, glycosylated hemoglobin; HDL-C, high-density lipoprotein cholesterol; LSG, laparoscopic sleeve gastrectomy; SFA, subcutaneous fat area; TC, total cholesterol; TG, triglyceride; %TWL, percent total weight loss; VFA, visceral fat area; γGTP, gamma-glutamyl transpeptidase.
As a definition of weight loss failure after bariatric surgery,
Reinhold's classification 17 of BMI >35 or % excess weight loss (EWL) <50% is widely used and, using this definition, the rate of weight loss failure was reported to be 20.4%. 18 However, the definition of weight loss failure using %TWL has not been established.
van de Laar et al 19 reported that ≥25% TWL was a useful criterion with sensitivity and specificity of 90%, but that ≥15% and ≥20%
TWL were inadequate criteria with specificity <30% for weight loss success with reference to the baseline BMI-independent weight loss percentile chart based on retrospective data after bariatric surgery. In the present study, diabetes remission rates were considerably lower in patients with %TWL <20% compared with higher %TWL. The ROC curve of %TWL at the optimal cut-off level of diabetes CR was 20.8%. There is a possibility that %TWL 20% is a candidate cut-off point of insufficient weight loss for diabetes remission after LSG. Furthermore, a lower remission rate of dyslipidemia was shown in patients with %TWL <15%. This is the first report that comprehensively investigated obesity-related comorbidities other than metabolic disorders in bariatric patients in Japan. In the systematic review conducted by Buchwald et al, 13 the prevalence of SAS, coronary artery disease, congestive heart failure and degenerative joint disease was 19.6, 7.0, 2.3 and 50.3%, respectively, in patients undergoing bariatric surgery. Jamal et al 20 reported that 5.5% of patients undergoing bariatric surgery had a history of polycystic ovary syndrome, whereas Musella et al 21 reported that 45.8% of patients were identified as having obesityrelated infertility. The prevalence of heart failure and joint disorders in our study was similar to these previous reports, whereas the prevalence of SAS was higher in our Japanese study. There are few reports on the beneficial effects of LSG on other obesity-related comorbidities. Previous reports showed that other bariatric surgery procedures such as laparoscopic Roux-en-Y gastric bypass improved cardiovascular risk factors, sleep apnea and joint pain, 13, 22, 23 which is supported by the findings in our study. Sarkhosh et al 24 found
that all the bariatric procedures achieved profound effects on SAS, and 85.7% of patients reported subjective improvement of SAS.
However, the relationship between %TWL and improvement in heart failure, menstrual disorder, joint disorders and SAS was not detected in the present study as a result of a lack of available data.
Further prospective investigation is required to elucidate how much weight obese patients need to lose to improve their comorbidities.
The present study is also the first nationwide survey in Japan to investigate the psychosocial background of morbidly obese patients. Previous studies have shown that 20.9%-37.8% of bariatric surgery candidates had at least one mental disorder at the time of preoperative evaluation. [25] [26] [27] The reported prevalence of eating disorders at the time of preoperative evaluation ranged from 7.1% to 16.3%. [25] [26] [27] In this Japanese survey, the prevalence of mental disorders was 26.3% and that of binge eating was 20.8%. There are several limitations in the present study. We carried out multivariate analysis to identify risk factors that caused insufficient weight loss after LSG; however, there was no independent factor identified (data not shown). The design was retrospective and observational. Lack of available data in some subjects could restrict the scope of our analysis. Also, the size of the sample analyzed could be a significant obstacle in identifying a trend and a significant relationship. The outcomes might also be influenced among institutions by various surgical techniques and surgeon's preference. Moreover, the small sample size is a critical problem, but this could not be avoided as a result of the current situation in Japan.
TA B L E 3 Other obesity-related comorbidities, psychosocial background, eating behavior and physical activity among %TWL groups Ischemic heart disease (%) Note: One-way ANOVA detected no statistically significant differences in these parameters among the %TWL groups. Abbreviations: AHI, apnea hypopnea index; SAS, sleep apnea syndrome; %TWL, percent total weight loss.
| CON CLUS IONS
This is the first nationwide survey in Japan to clarify the relationship between insufficient weight loss after LSG, metabolic remission and psychosocial background. Our study showed that mean %TWL was 29.9%, and that weight loss resulted in significant improvement in obesity-related comorbidities. %TWL 20% might be an optimal cut-off point for diabetes remission in Japanese obese 
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F I G U R E 3
Prevalence of mental disorders stratified by percent total weight loss (%TWL). (A) Patients were divided into eight groups according to %TWL (every 5% of TWL). Relationship between frequency of mental disorders and %TWL was a U-shaped curve, and the trend was significant using Fisher's exact test (P = .0046). (B) In patients with %TWL <15%, the frequency was 46.9% and significantly higher than in those with %TWL ≥15% (P = .0101). (C) Frequency in patients with %TWL ≥45% was also significantly higher than in those with %TWL <45%
F I G U R E 4 Changes in (A) body weight and (B) daily calorie intake in patients with percent total weight loss (%TWL) <15% compared with %TWL ≥15%. In patients with %TWL <15%, significant weight regain was observed from 1 y after laparoscopic sleeve gastrectomy (LSG) (mean body weight was 99.8 kg at 1 y and 106.2 kg at 2 y, P = .0002). In patients with %TWL <15%, daily calorie intake at 2 y after LSG was significantly higher compared to %TWL ≥15% (2012.4 vs 1339.2 kcal/d, P < .0001), and a significant (P = .0486) increase in daily calorie intake from 1 y (1666.8 kcal/d) to 2 y after LSG (2012.4 kcal/d) was observed
